Sign Out
Avemar is a dietary supplement for cancer patients.
Avemar is indicated for supplementing the clinical oncological procedures (surgery, radiotherapy, chemotherapy, immunotherapy etc.) of cancer patients. Avemar can be used in cancer related cachexia. Avemar is indicated to be taken without interruption before, during the full course and after the completion of oncological treatments. Avemar is recommended at any stage of malignant disease. After surgery, Avemar may be initiated when the patient is able to take oral food without complications for at least 4 days.
It is recommended to start taking Avemar right after the recognition of malignant disease (diagnoses). There is no need to wait for the start of the oncological treatment.
